Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

genetic mutations

  • Open Access
    TP53, PIK3CA, FBXW7 and KRAS Mutations in Esophageal Cancer Identified by Targeted Sequencing
    HUILI ZHENG, YAN WANG, CHUANNING TANG, LINDSEY JONES, HUA YE, GUANGCHUN ZHANG, WEIHAI CAO, JINGWEN LI, LIFENG LIU, ZHENCONG LIU, CHAO ZHANG, FENG LOU, ZHIYUAN LIU, YANGYANG LI, ZHENFEN SHI, JINGBO ZHANG, DANDAN ZHANG, HONG SUN, HAICHAO DONG, ZHISHOU DONG, BAISHUAI GUO, HE YAN, QINGYU LU, XUE HUANG and SI-YI CHEN
    Cancer Genomics & Proteomics May 2016, 13 (3) 231-238;
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire